癌症治疗相关的血栓。
Cancer Therapy-Associated Thrombosis.
机构信息
UNC Blood Research Center, Division of Hematology and Oncology, Department of Medicine, University of North Carolina at Chapel Hill.
出版信息
Arterioscler Thromb Vasc Biol. 2021 Apr;41(4):1291-1305. doi: 10.1161/ATVBAHA.120.314378. Epub 2021 Feb 11.
Abstract
[Figure: see text].
摘要
[图：见正文]。
相似文献
1
Cancer Therapy-Associated Thrombosis.癌症治疗相关的血栓。
Arterioscler Thromb Vasc Biol. 2021 Apr;41(4):1291-1305. doi: 10.1161/ATVBAHA.120.314378. Epub 2021 Feb 11.
2
High-density lipoprotein as a modulator of platelet and coagulation responses.高密度脂蛋白作为血小板和凝血反应的调节剂。
Cardiovasc Res. 2014 Aug 1;103(3):362-71. doi: 10.1093/cvr/cvu137. Epub 2014 Jun 1.
3
Arterial Thrombotic Complications of Tyrosine Kinase Inhibitors.酪氨酸激酶抑制剂的动脉血栓并发症。
Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):3-10. doi: 10.1161/ATVBAHA.120.314694. Epub 2020 Dec 4.
4
Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.水溶性一氧化碳释放分子的抗血栓特性。
Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2149-57. doi: 10.1161/ATVBAHA.112.253989. Epub 2012 Jul 5.
5
Collagen-induced thrombosis in murine arteries and veins.胶原诱导的鼠动静脉血栓形成。
Thromb Res. 2013 Jan;131(1):49-54. doi: 10.1016/j.thromres.2012.09.019. Epub 2012 Oct 9.
6
Evaluation of AR-H067637, the active metabolite of the new direct thrombin inhibitor AZD0837, in models of venous and arterial thrombosis and bleeding in anaesthetised rats.评价新型直接凝血酶抑制剂 AZD0837 的活性代谢物 AR-H067637 在麻醉大鼠静脉和动脉血栓形成及出血模型中的作用。
Thromb Haemost. 2010 Dec;104(6):1242-9. doi: 10.1160/TH09-10-0744. Epub 2010 Aug 30.
7
Management of cancer-associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH.血小板减少症患者癌症相关血栓形成的管理：国际血栓与止血学会（ISTH）科学和标准化委员会的指南
J Thromb Haemost. 2018 Jun;16(6):1246-1249. doi: 10.1111/jth.14015. Epub 2018 May 8.
8
Venous thromboembolism in oncology.肿瘤学中的静脉血栓栓塞
Eksp Onkol. 2004 Mar;26(1):11-4.
9
Arterial thrombosis and anti-PD-1 blockade.动脉血栓形成与抗程序性死亡蛋白1阻断疗法
Eur J Cancer. 2018 Mar;91:164-166. doi: 10.1016/j.ejca.2017.11.018. Epub 2017 Dec 27.
引用本文的文献
1
Arterial and venous thromboembolic events in patients with cancer treated with targeted therapies: a population-based cohort study.接受靶向治疗的癌症患者的动脉和静脉血栓栓塞事件：一项基于人群的队列研究。
EClinicalMedicine. 2025 Aug 21;87:103440. doi: 10.1016/j.eclinm.2025.103440. eCollection 2025 Sep.
2
Practical considerations about management of pulmonary embolism in patients with cancer.癌症患者肺栓塞管理的实际考量
J Thromb Thrombolysis. 2025 Aug 29. doi: 10.1007/s11239-025-03122-1.
3
Association of risk factors for venous thromboembolism and overall survival in lung cancer.肺癌患者静脉血栓栓塞危险因素与总生存期的相关性
Blood Vessel Thromb Hemost. 2025 May 9;2(3):100074. doi: 10.1016/j.bvth.2025.100074. eCollection 2025 Aug.
4
Apoptotic cells promote circulating tumor cell survival and metastasis.凋亡细胞促进循环肿瘤细胞的存活和转移。
Commun Biol. 2025 Jul 29;8(1):1121. doi: 10.1038/s42003-025-08541-7.
5
Near-fatal saddle pulmonary embolism following chemoradiotherapy and brachytherapy for locally advanced cervical cancer: A case series.局部晚期宫颈癌放化疗及近距离放疗后发生的近乎致命性鞍状肺栓塞：病例系列
J Contemp Brachytherapy. 2025 Jun;17(3):197-201. doi: 10.5114/jcb.2025.152543. Epub 2025 Jun 30.
6
Thromboembolism in patients with melanoma receiving immune checkpoint inhibitors: incidence and risk factors.接受免疫检查点抑制剂治疗的黑色素瘤患者的血栓栓塞：发病率及危险因素
Immunooncol Technol. 2025 Jun 21;27:101063. doi: 10.1016/j.iotech.2025.101063. eCollection 2025 Sep.
7
Inconsistent and Inaccurate Cancer Clinical Trial Reporting of Venous and Arterial Thrombotic Events: An Urgent Call to Action.静脉和动脉血栓形成事件的癌症临床试验报告不一致且不准确：紧急呼吁采取行动。
J Clin Oncol. 2025 Jun 25:JCO2500489. doi: 10.1200/JCO-25-00489.
8
Postmarketing safety evaluation of pemetrexed using FAERS and JADER databases.使用FAERS和JADER数据库对培美曲塞进行上市后安全性评估。
Sci Rep. 2025 May 28;15(1):18738. doi: 10.1038/s41598-025-02426-9.
9
Specific Cardiovascular Mortality in Cancer Survivors: A Nationwide Population-Based Cohort Study in Japan.癌症幸存者的特定心血管疾病死亡率：日本一项基于全国人口的队列研究
J Am Heart Assoc. 2025 May 20;14(10):e037965. doi: 10.1161/JAHA.124.037965. Epub 2025 May 15.
10
Challenges and Opportunities of Direct Oral Anticoagulant (DOAC) Therapy in Complex Clinical Scenarios: A Comprehensive Review and Practical Guide.直接口服抗凝剂（DOAC）疗法在复杂临床场景中的挑战与机遇：全面综述与实用指南
J Clin Med. 2025 Apr 23;14(9):2914. doi: 10.3390/jcm14092914.
本文引用的文献
1
Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy.免疫检查点抑制剂治疗中静脉和动脉血栓栓塞的发生率、风险因素和结局。
Blood. 2021 Mar 25;137(12):1669-1678. doi: 10.1182/blood.2020007878.
2
Venous and arterial thromboembolic events with immune checkpoint inhibitors: A systematic review.免疫检查点抑制剂相关的静脉和动脉血栓栓塞事件：系统评价。
Thromb Res. 2020 Dec;196:444-453. doi: 10.1016/j.thromres.2020.09.038. Epub 2020 Oct 8.
3
Gemcitabine and Platinum-Based Agents for the Prediction of Cancer-Associated Venous Thromboembolism: Results from the Vienna Cancer and Thrombosis Study.吉西他滨与铂类药物对癌症相关静脉血栓栓塞的预测作用：来自维也纳癌症与血栓形成研究的结果
Cancers (Basel). 2020 Sep 3;12(9):2493. doi: 10.3390/cancers12092493.
4
Thrombosis in hematological malignancies: mechanisms and implications.血液恶性肿瘤中的血栓形成：机制与意义。
Thromb Res. 2020 Jul;191 Suppl 1:S58-S62. doi: 10.1016/S0049-3848(20)30398-4.
5
Venous thromboembolism risk in patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with combined CDK 4/6 inhibitors plus endocrine therapy versus endocrine therapy alone: a systematic review and meta-analysis of randomized controlled trials.激素受体阳性 HER2 阴性转移性乳腺癌患者接受 CDK4/6 抑制剂联合内分泌治疗与单独内分泌治疗相比的静脉血栓栓塞风险：系统评价和随机对照试验的荟萃分析。
Breast Cancer Res Treat. 2020 Sep;183(2):479-487. doi: 10.1007/s10549-020-05783-3. Epub 2020 Jul 9.
6
Effect of chemotherapy and longitudinal analysis of circulating extracellular vesicle tissue factor activity in patients with pancreatic and colorectal cancer.化疗对胰腺癌和结直肠癌患者循环细胞外囊泡组织因子活性的影响及纵向分析
Res Pract Thromb Haemost. 2020 Mar 9;4(4):636-643. doi: 10.1002/rth2.12317. eCollection 2020 May.
7
Doxorubicin contributes to thrombus formation and vascular injury by interfering with platelet function.多柔比星通过干扰血小板功能导致血栓形成和血管损伤。
Am J Physiol Heart Circ Physiol. 2020 Jul 1;319(1):H133-H143. doi: 10.1152/ajpheart.00456.2019. Epub 2020 May 29.
8
Thromboembolism prophylaxis in adult patients with acute lymphoblastic leukemia treated in the GRAALL-2005 study.急性淋巴细胞白血病成人患者 GRAALL-2005 研究中的血栓栓塞预防。
Blood. 2020 Jul 16;136(3):328-338. doi: 10.1182/blood.2020004919.
9
Arterial Thrombosis in Cancer: Spotlight on the Neglected Vessels.癌症相关的动脉血栓形成：被忽视的血管。
Anticancer Res. 2019 Sep;39(9):4619-4625. doi: 10.21873/anticanres.13642.
10
Venous thromboembolism in breast cancer patients receiving cyclin-dependent kinase inhibitors.接受细胞周期蛋白依赖性激酶抑制剂治疗的乳腺癌患者的静脉血栓栓塞
J Thromb Haemost. 2020 Jan;18(1):162-168. doi: 10.1111/jth.14630. Epub 2019 Sep 18.
Zotero 插件